ELV Long Call Strategy
ELV (Elevance Health Inc.), in the Healthcare sector, (Medical - Healthcare Plans industry), listed on NYSE.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
ELV (Elevance Health Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Plans, with a market capitalization of approximately $85.82B, a trailing P/E of 16.62, a beta of 0.68 versus the broader market, a 52-week range of 273.71-426.98, average daily share volume of 1.7M, a public-listing history dating back to 2001, approximately 104K full-time employees. These structural characteristics shape how ELV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.68 indicates ELV has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. ELV pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on ELV?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ELV snapshot
As of June 30, 2026, spot at $387.25, ATM IV 40.60%, IV rank 43.09%, expected move 11.64%. The long call on ELV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long call structure on ELV specifically: ELV IV at 40.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 11.64% (roughly $45.07 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ELV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ELV should anchor to the underlying notional of $387.25 per share and to the trader's directional view on ELV stock.
ELV long call setup
The ELV long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ELV near $387.25, the first option leg uses a $390.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ELV chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ELV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $390.00 | $13.15 |
ELV long call risk and reward
- Net Premium / Debit
- -$1,315.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$1,315.00
- Breakeven(s)
- $403.15
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ELV long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ELV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$1,315.00 |
| $85.63 | -77.9% | -$1,315.00 |
| $171.25 | -55.8% | -$1,315.00 |
| $256.88 | -33.7% | -$1,315.00 |
| $342.50 | -11.6% | -$1,315.00 |
| $428.12 | +10.6% | +$2,497.01 |
| $513.74 | +32.7% | +$11,059.21 |
| $599.36 | +54.8% | +$19,621.41 |
| $684.99 | +76.9% | +$28,183.61 |
| $770.61 | +99.0% | +$36,745.81 |
When traders use long call on ELV
Long calls on ELV express a bullish thesis with defined risk; traders use them ahead of ELV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ELV thesis for this long call
The market-implied 1-standard-deviation range for ELV extends from approximately $342.18 on the downside to $432.32 on the upside. A ELV long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ELV IV rank near 43.09% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ELV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ELV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ELV-specific events.
ELV long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ELV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ELV alongside the broader basket even when ELV-specific fundamentals are unchanged. Long-premium structures like a long call on ELV are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ELV chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ELV?
- A long call on ELV is the long call strategy applied to ELV (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ELV stock trading near $387.25, the strikes shown on this page are snapped to the nearest listed ELV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ELV long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ELV long call priced from the end-of-day chain at a 30-day expiry (ATM IV 40.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,315.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ELV long call?
- The breakeven for the ELV long call priced on this page is roughly $403.15 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ELV market-implied 1-standard-deviation expected move is approximately 11.64%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ELV?
- Long calls on ELV express a bullish thesis with defined risk; traders use them ahead of ELV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ELV implied volatility affect this long call?
- ELV ATM IV is at 40.60% with IV rank near 43.09%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.